Skip to main content
. 2021 Mar 12;4(3):e211785. doi: 10.1001/jamanetworkopen.2021.1785

Figure. Kaplan-Meier Survival Curve for Overall Survival in Patients With Strongly Hormone Receptor–Positive and Human Epidermal Growth Factor Receptor 2–Negative Invasive Ductal Carcinoma Receiving Neoadjuvant Treatments.

Figure.

NACT indicates neoadjuvant chemotherapy; NET, neoadjuvant endocrine therapy.